Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF Inhibition

Dysregulated metabolism can broadly affect therapy resistance by influencing compensatory signaling and expanding proliferation. Given many BRAF-mutated melanoma patients experience disease progression with targeted BRAF inhibitors, we hypothesized therapeutic response is related to tumor metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardeman, Keisha N., Peng, Chengwei, Paudel, Bishal B., Meyer, Christian T., Luong, Thong, Tyson, Darren R., Young, Jamey D., Quaranta, Vito, Fessel, Joshua P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311997/
https://www.ncbi.nlm.nih.gov/pubmed/28205616
http://dx.doi.org/10.1038/srep42604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311997/
https://www.ncbi.nlm.nih.gov/pubmed/28205616
http://dx.doi.org/10.1038/srep42604

Ejemplares similares